Innotech

InnoTech Precision Medicine is a developer of point-of-care diagnostic platforms. The company is developing a new device for the early detection of COVID-19, other infectious diseases, and cancer.InnoTech Precision Medicine's mission is to develop a platform that enables rapid, accurate, low-cost, and field-deployable early point-of-care/self-testing diagnostics for diseases through easily accessible liquid biopsies. The platform, named Recognize™, uses synthetic biosensors that allow for the selective and refined design and manufacture of any macromolecule within weeks.